nach oben

HNO

Erschienen in:

01.01.2012 | Leitthema

Larynxkarzinom

Epidemiologie, Risikofaktoren und Überleben

verfasst von: M. Pantel, Univ.-Prof. Dr. O. Guntinas-Lichius

Erschienen in: HNO | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Das Larynxkarzinom gehört zu den häufigen Kopf-Hals-Tumoren mit einer rückläufigen Erkrankungsrate bei Männern und weiteren Zunahme bei Frauen. Die Inzidenz beträgt in Deutschland etwa 5–7/100.000 Personen/Jahr bei Männern und etwa 0,6–0,8/100.000 Personen/Jahr bei Frauen. Bedingt durch die höhere Lebenserwartung nimmt das mittlere Erkrankungsalter zu; bei adäquater Vorbereitung kann jedoch auch bei älteren Patienten eine Standardtherapie mit gleichen Überlebenschancen wie bei jüngeren durchgeführt werden. Tabakrauchen und Alkoholkonsum bleiben auch heute die dominierenden Risikofaktoren bei mehr als 80% der Patienten. Trotz einer Vielzahl von diagnostischen Neuerungen wird immer noch die Hälfte der Tumoren erst im fortgeschrittenen Stadium erkannt. Auch die Überlebensraten haben sich in Deutschland in den letzten 10 Jahren nicht signifikant verbessert. Die durchschnittliche 5-Jahres-Überlebensrate liegt in Deutschland bei etwa 60%. Über eine Abnahme der Überlebensraten, wie in den USA beobachtet, ist anderseits aber nicht zu berichten.

Abbasi R, Ramroth H, Becher H et al (2009) Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer 125:1431–1439PubMedCrossRef

Krebs in Deutschland 2005/2006. Robert Koch-Institut, Berlin, 2010

Bagnardi V, Blangiardo M, La Vecchia C et al (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85:1700–1705PubMedCrossRef

Barnes L (2000) Diseases of the larynx, hypopharynx and esophagus. Marcel Dekker, New York

Becher H, Ramroth H, Ahrens W et al (2005) Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk. Int J Cancer 116:451–457PubMedCrossRef

Boffetta P, Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7:149–156PubMedCrossRef

Booth CM, Li G, Zhang-Salomons J et al (2010) The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer 116:4160–4167PubMedCrossRef

Bosetti C, Gallus S, Peto R et al (2008) Tobacco smoking, smoking cessation, and cumulative risk of upper aerodigestive tract cancers. Am J Epidemiol 167:468–473PubMedCrossRef

Bosetti C, Scelo G, Chuang SC et al (2011) High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries. Int J Cancer 129:173–179PubMedCrossRef

10.

Canova C, Hashibe M, Simonato L et al (2009) Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res 69:2956–2965PubMedCrossRef

11.

Carvalho AL, Nishimoto IN, Califano JA et al (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114:806–816PubMedCrossRef

12.

Chen AY, Fedewa S, Pavluck A et al (2010) Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer 116:4744–4752PubMedCrossRef

13.

Cook MB, Dawsey SM, Freedman ND et al (2009) Sex disparities in cancer incidence by period and age. A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cancer Epidemiol Biomarkers Prev 18:1174–1182PubMedCrossRef

14.

Cooper JS, Porter K, Mallin K et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31:748–758PubMedCrossRef

15.

Cosetti M, Yu GP, Schantz SP (2008) Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 134:370–379PubMedCrossRef

16.

Datema FR, Ferrier MB, Van Der Schroeff MP et al (2010) Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck 32:728–736PubMedCrossRef

17.

Deleyiannis FW, Thomas DB, Vaughan TL et al (1996) Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst 88:542–549PubMedCrossRef

18.

Dietz A, Frerich B (2009) Current opinion in treatment of soft tissue sarcoma. Laryngorhinootologie 88:293–302PubMedCrossRef

19.

Dietz A, Ramroth H, Urban T et al (2004) Exposure to cement dust, related occupational groups and laryngeal cancer risk: results of a population based case-control study. Int J Cancer 108:907–911PubMedCrossRef

20.

Do KA, Johnson MM, Lee JJ et al (2004) Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer 101:2837–2842PubMedCrossRef

21.

Doyle DJ, Henderson LA, Lejeune FE Jr et al (1994) Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm. Arch Otolaryngol Head Neck Surg 120:1273–1276PubMedCrossRef

22.

Duffy SA, Khan MJ, Ronis DL et al (2008) Health behaviors of head and neck cancer patients the first year after diagnosis. Head Neck 30:93–102PubMedCrossRef

23.

Duffy SA, Ronis DL, Valenstein M et al (2007) Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics 48:142–148PubMedCrossRef

24.

Franceschi S, Talamini R, Barra S et al (1990) Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 50:6502–6507PubMed

25.

Garces YI, Schroeder DR, Nirelli LM et al (2007) Second primary tumors following tobacco dependence treatments among head and neck cancer patients. Am J Clin Oncol 30:531–539PubMedCrossRef

26.

Gourin CG, Conger BT, Sheils WC et al (2009) The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 119:1312–1317PubMedCrossRef

27.

Gourin CG, Forastiere AA, Sanguineti G et al (2011) Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care. Laryngoscope 121:85–90PubMedCrossRef

28.

Gourin CG, Forastiere AA, Sanguineti G et al (2011) Volume-based trends in laryngeal cancer surgery. Laryngoscope 121:77–84PubMedCrossRef

29.

Green GE, Bauman NM, Smith RJ (2000) Pathogenesis and treatment of juvenile onset recurrent respiratory papillomatosis. Otolaryngol Clin North Am 33:187–207PubMedCrossRef

30.

Gritz ER, Schacherer C, Koehly L et al (1999) Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 21:420–427PubMedCrossRef

31.

Groome PA, Schulze KM, Keller S et al (2006) Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol) 18:283–292

32.

Guntinas-Lichius O, Wendt T, Buentzel J et al (2010) Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 136:55–63PubMedCrossRef

33.

Hakulinen T, Engholm G, Gislum M et al (2010) Trends in the survival of patients diagnosed with cancers in the respiratory system in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 49:608–623PubMedCrossRef

34.

Ho T, Wei Q, Sturgis EM (2007) Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck. Head Neck 29:682–699PubMedCrossRef

35.

Hoffman HT, Karnell LH, Funk GF et al (1998) The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 124:951–962PubMed

36.

Hoffman, Porter K, Karnell LH et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116:1–13PubMedCrossRef

37.

Islami F, Tramacere I, Rota M et al (2010) Alcohol drinking and laryngeal cancer: overall and dose-risk relation-a systematic review and meta-analysis. Oral Oncol 46:802–810PubMedCrossRef

38.

La Vecchia C, Bosetti C, Lucchini F et al (2010) Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 21:1323–1360CrossRef

39.

Lang S, Wollenberg B, Dellian M et al (2002) Clinical and epidemiological data of patients with malignomas of the head and neck. Laryngorhinootologie 81:499–508PubMedCrossRef

40.

Lee YC, Marron M, Benhamou S et al (2009) Active and involuntary tobacco smoking and upper aerodigestive tract cancer risks in a multicenter case-control study. Cancer Epidemiol Biomarkers Prev 18:3353–3361PubMedCrossRef

41.

Lewis JS Jr, Ferlito A, Gnepp DR et al (2011) Terminology and classification of neuroendocrine neoplasms of the larynx. Laryngoscope 121:1187–1193PubMedCrossRef

42.

Lin HW, Bhattacharyya N (2008) Staging and survival analysis for nonsquamous cell carcinomas of the larynx. Laryngoscope 118:1003–1013PubMedCrossRef

43.

Lubin JH, Muscat J, Gaudet MM et al (2011) An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies. Cancer Causes Control 22:1217–1231PubMedCrossRef

44.

Lubin JH, Purdue M, Kelsey K et al (2009) Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol 170:937–947PubMedCrossRef

45.

Maier H, Dietz A, Gewelke U et al (1992) Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 70:320–327PubMedCrossRef

46.

Maier H, Tisch M (1999) Beruf und Krebs im Kopf-Hals-Bereich. HNO 47:1025–1037PubMedCrossRef

47.

Morris LG, Sikora AG, Patel SG et al (2011) Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol 29:739–746PubMedCrossRef

48.

Moukarbel RV, Goldstein DP, O’sullivan B et al (2008) Adenoid cystic carcinoma of the larynx: a 40-year experience. Head Neck 30:919–924PubMedCrossRef

49.

Mozet C, Dietz A (2010) Laryngeal neoplasms. Laryngorhinootologie 89:295–315PubMedCrossRef

50.

Park SL, Lee YC, Marron M et al (2011) The association between change in body mass index and upper aerodigestive tract cancers in the ARCAGE project: multicenter case-control study. Int J Cancer 128:1449–1461PubMedCrossRef

51.

Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef

52.

Pelucchi C, Gallus S, Garavello W et al (2008) Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 17:340–344PubMedCrossRef

53.

Peters TT, Van Der Laan BF, Plaat BE et al (2011) The impact of comorbidity on treatment-related side effects in older patients with laryngeal cancer. Oral Oncol 47:56–61PubMedCrossRef

54.

Polesel J, Talamini R, La Vecchia C et al (2008) Tobacco smoking and the risk of upper aero-digestive tract cancers: a reanalysis of case-control studies using spline models. Int J Cancer 122:2398–2402PubMedCrossRef

55.

Rady PL, Schnadig VJ, Weiss RL et al (1998) Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 108:735–740PubMedCrossRef

56.

Ramroth H, Dietz A, Ahrens W et al (2008) Occupational wood dust exposure and the risk of laryngeal cancer: a population based case-control study in Germany. Am J Ind Med 51:648–655PubMedCrossRef

57.

Rehm J, Patra J, Popova S (2007) Alcohol drinking cessation and its effect on esophageal and head and neck cancers: a pooled analysis. Int J Cancer 121:1132–1137PubMedCrossRef

58.

Reizenstein JA, Bergstrom SN, Holmberg L et al (2010) Impact of age at diagnosis on prognosis and treatment in laryngeal cancer. Head Neck 32:1062–1068PubMedCrossRef

59.

Rudolph E, Dyckhoff G, Becher H et al (2011) Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Eur Arch Otorhinolaryngol 268:165–179PubMedCrossRef

60.

Sakakura A, Yamamoto Y, Takasaki T et al (1996) Recurrent laryngeal papillomatosis developing into laryngeal carcinoma with human papilloma virus (HPV) type 18: a case report. J Laryngol Otol 110:75–77PubMedCrossRef

61.

Sant M, Aareleid T, Berrino F et al (2003) EUROCARE-3: survival of cancer patients diagnosed 1990–94-results and commentary. Ann Oncol 14(Suppl 5):v61–v118PubMedCrossRef

62.

Sant M, Allemani C, Santaquilani M et al (2009) EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 45:931–991PubMedCrossRef

63.

Scarselli A, Binazzi A, Forastiere F et al (2011) Industry and job-specific mortality after occupational exposure to silica dust. Occup Med (Lond) 61(6):422:429

64.

Singer S, Keszte J, Thiele A et al (2010) Smoking behaviour after laryngectomy. Laryngorhinootologie 89:146–150PubMedCrossRef

65.

Solomon D, Smith RR, Kashima HK et al (1985) Malignant transformation in non-irradiated recurrent respiratory papillomatosis. Laryngoscope 95:900–904PubMedCrossRef

66.

Weikert C, Dietrich T, Boeing H et al (2009) Lifetime and baseline alcohol intake and risk of cancer of the upper aero-digestive tract in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Cancer 125:406–412PubMedCrossRef

67.

Zhang H, Travis LB, Chen R et al (2011) Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients. Cancer: [epub ahead of print] doi: 10.1002/cncr.26357

68.

Zhang M, Marugame T (2010) Comparison of time trends in larynx cancer mortality (1990–2006) between countries based on the WHO mortality database. Jpn J Clin Oncol 40:820–821PubMedCrossRef

Titel: Larynxkarzinom
Epidemiologie, Risikofaktoren und Überleben
verfasst von: M. Pantel
Univ.-Prof. Dr. O. Guntinas-Lichius
Publikationsdatum: 01.01.2012
Verlag: Springer-Verlag
Erschienen in: HNO / Ausgabe 1/2012
Print ISSN: 0017-6192
Elektronische ISSN: 1433-0458
DOI: https://doi.org/10.1007/s00106-011-2423-8

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Larynxkarzinom

Epidemiologie, Risikofaktoren und Überleben

Zusammenfassung

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Werden mit dem SETK 3–5 klinisch diagnostizierte Sprachentwicklungsstörungen erfasst?

Fortschritte der endoskopischen Diagnostik von Dysplasien und Karzinomen des Larynx

Rezeptorfunktion der Bogengänge

Patienten mit dem Wunsch nach einer funktionell-ästhetischen Nasenoperation

Aktuelle Therapieoptionen bei Larynx- und Hypopharynxkarzinomen

Multimodaler Larynxerhalt

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO